Eric Park

1.3k total citations
16 papers, 980 citations indexed

About

Eric Park is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Eric Park has authored 16 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Surgery. Recurrent topics in Eric Park's work include Lysosomal Storage Disorders Research (6 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Reproductive Biology and Fertility (2 papers). Eric Park is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Reproductive Biology and Fertility (2 papers). Eric Park collaborates with scholars based in United States, Spain and Canada. Eric Park's co-authors include Emily M. Rocha, Gaynor A. Smith, Penelope J. Hallett, Ole Isacson, Hongmei Cao, Timothy W. Secomb, Richard Hsu, Mark W. Dewhirst, Martin L. Yarmush and Mehmet Toner and has published in prestigious journals such as The FASEB Journal, Biophysical Journal and Antioxidants and Redox Signaling.

In The Last Decade

Eric Park

15 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Park United States 8 341 290 265 224 102 16 980
Matthias Mehling Switzerland 25 140 0.4× 506 1.7× 151 0.6× 977 4.4× 54 0.5× 47 2.7k
Silvia Jansen United States 18 101 0.3× 258 0.9× 614 2.3× 775 3.5× 75 0.7× 26 1.8k
Kelly M. Gillen United States 18 86 0.3× 156 0.5× 109 0.4× 323 1.4× 98 1.0× 36 1.3k
Eva Faurobert France 20 57 0.2× 283 1.0× 337 1.3× 696 3.1× 51 0.5× 37 1.3k
Tyler D. Ross United States 9 178 0.5× 61 0.2× 430 1.6× 474 2.1× 137 1.3× 11 1.1k
Josef Zámečnı́k Czechia 24 111 0.3× 187 0.6× 141 0.5× 674 3.0× 174 1.7× 117 1.8k
Daniel Metcalf United Kingdom 13 196 0.6× 113 0.4× 296 1.1× 343 1.5× 27 0.3× 14 864
Nalan Liv Netherlands 20 151 0.4× 59 0.2× 333 1.3× 808 3.6× 112 1.1× 44 1.6k
Inkyung Kang United States 18 257 0.8× 36 0.1× 540 2.0× 493 2.2× 108 1.1× 29 1.4k
D Drenckhahn Germany 15 282 0.8× 49 0.2× 399 1.5× 697 3.1× 188 1.8× 18 1.5k

Countries citing papers authored by Eric Park

Since Specialization
Citations

This map shows the geographic impact of Eric Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Park more than expected).

Fields of papers citing papers by Eric Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Park. The network helps show where Eric Park may publish in the future.

Co-authorship network of co-authors of Eric Park

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Park. A scholar is included among the top collaborators of Eric Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Park. Eric Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yoo, Seungyeul, Feng Jiang, Eric Park, et al.. (2025). Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma. iScience. 28(5). 112387–112387.
2.
Yuan, Shipeng, et al.. (2025). Reversing Pathology in an Aggravated Fabry Mouse Model Using Low-Dose Engineered Human Alpha-Galactosidase A AAV Gene Therapy. Biomedicines. 13(3). 577–577. 2 indexed citations
3.
Yuan, Shipeng, et al.. (2024). Developing Gene Therapy for Mitigating Multisystemic Pathology in Fabry Disease: Proof of Concept in an Aggravated Mouse Model. Human Gene Therapy. 35(17-18). 680–694. 3 indexed citations
4.
Sheng, Yi, Eric Park, Peike Sheng, et al.. (2024). A mitochondrial unfolded protein response-independent role of DVE-1 in longevity regulation. Cell Reports. 43(11). 114889–114889. 1 indexed citations
5.
Chen, Nancy, et al.. (2023). Preventing Fabry disease progression in a symptomatic mouse model with a recombinant adeno-associated virus (rAAV) based gene therapy. Molecular Genetics and Metabolism. 138(2). 107164–107164. 1 indexed citations
6.
Yuan, Shipeng, et al.. (2023). Characterization of the G3Stg/KO Fabry disease mouse model pathology to improve preclinical to clinical translation. Molecular Genetics and Metabolism. 138(2). 107034–107034. 3 indexed citations
7.
Rocha, Emily M., Gaynor A. Smith, Eric Park, et al.. (2015). Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice. Antioxidants and Redox Signaling. 23(6). 550–564. 117 indexed citations
8.
Rocha, Emily M., Gaynor A. Smith, Eric Park, et al.. (2015). Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. Neurobiology of Disease. 82. 495–503. 129 indexed citations
9.
Rocha, Emily M., Gaynor A. Smith, Eric Park, et al.. (2015). Progressive decline of glucocerebrosidase in aging and P arkinson's disease. Annals of Clinical and Translational Neurology. 2(4). 433–438. 172 indexed citations
10.
Eda, Hiroyuki, Katherine M. Kulig, Hideaki Shimada, et al.. (2012). A Nanofiber Membrane Maintains the Quiescent Phenotype of Hepatic Stellate Cells. Digestive Diseases and Sciences. 57(5). 1152–1162. 3 indexed citations
11.
He, Xiaoming, Eric Park, Alex Fowler, Martin L. Yarmush, & Mehmet Toner. (2008). Vitrification by ultra-fast cooling at a low concentration of cryoprotectants in a quartz micro-capillary: A study using murine embryonic stem cells. Cryobiology. 56(3). 223–232. 113 indexed citations
12.
Cho, Cheul H., Natesh Parashurama, Eric Park, et al.. (2007). Homogeneous differentiation of hepatocyte‐like cells from embryonic stem cells: applications for the treatment of liver failure. The FASEB Journal. 22(3). 898–909. 67 indexed citations
13.
He, Xiaoming, Heidi Elmoazzen, Ramón Risco, et al.. (2007). 104. Vitrification of mammalian cells by Ultra-fast cooling using a low concentration of cryoprotectants with quartz capillaries. Cryobiology. 55(3). 359–359. 3 indexed citations
14.
Secomb, Timothy W., Richard Hsu, Eric Park, & Mark W. Dewhirst. (2004). Green's Function Methods for Analysis of Oxygen Delivery to Tissue by Microvascular Networks. Annals of Biomedical Engineering. 32(11). 1519–1529. 166 indexed citations
15.
Weisberg, Ilan, Eric Park, Karla V. Ballman, et al.. (2003). Investigations of a common genetic variant in betaine–homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis. 167(2). 205–214. 75 indexed citations
16.
Park, Eric, McRae J. Smith, Karen R. Snapp, et al.. (2002). Comparison of PSGL-1 Microbead and Neutrophil Rolling: Microvillus Elongation Stabilizes P-Selectin Bond Clusters. Biophysical Journal. 82(4). 1835–1847. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026